Stay updated on Immunotherapy for Metastatic Cancers with CDK12 Mutations Clinical Trial
Sign up to get notified when there's something new on the Immunotherapy for Metastatic Cancers with CDK12 Mutations Clinical Trial page.

Latest updates to the Immunotherapy for Metastatic Cancers with CDK12 Mutations Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe revision tag on the page updates from v3.6.5 to v3.6.6, indicating a new build. No study details, eligibility criteria, or results content were changed.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedThe page's revision stamp was updated from v3.6.4 to v3.6.5, indicating a frontend update to this ClinicalTrials.gov page.SummaryDifference0.0%

- Check42 days agoChange DetectedNo additions or deletions were found on the page. The current study details remain unchanged.SummaryDifference0.0%

- Check49 days agoChange DetectedThe page revision was updated from v3.6.3 to v3.6.4, indicating a small system or UI update to the study record display.SummaryDifference0.1%

- Check71 days agoChange DetectedRevision updated from v3.6.2 to v3.6.3, indicating deployment of site updates; the study page content remains unchanged.SummaryDifference0.0%

- Check78 days agoChange DetectedUpdated the page revision tag from v3.6.0 to v3.6.2, indicating a new build of the page. This change affects only metadata and does not alter visible content or interactions.SummaryDifference0.0%

Stay in the know with updates to Immunotherapy for Metastatic Cancers with CDK12 Mutations Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunotherapy for Metastatic Cancers with CDK12 Mutations Clinical Trial page.